학술논문
Pharmacokinetics, Safety, and Tolerability of a 2-Month Dose Interval Regimen of the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: Results From a 44-Week Phase I Study
Document Type
Article
Author
Source
In: CNS Drugs . (CNS Drugs, 1 September 2020, 34(9):961-972)
Subject
Language
English
ISSN
11791934
11727047
11727047